MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajog.2024.10.022

Медицинская библиотека · American journal of obstetrics and gynecology · 2024

Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity.

Kanbergs Alexa, Clapp Mark, Wu Chi-Fang, Melamed Alexander, Agusti Nuria, Viveros-Carreño David, Zamorano Abigail S, Virili Florencia, Rauh-Hain Jose Alejandro, Nitecki Wilke Roni

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Data on maternal and fetal outcomes in patients diagnosed with cancer during pregnancy are limited. Given expected increase in patients diagnosed with cancer during pregnancy, there is a growing need to evaluate clinical outcomes.

OBJECTIVE

To evaluate obstetric outcomes among women with early-stage gynecologic or breast cancer who were diagnosed during pregnancy compared to women without cancer in a population-based cohort.

STUDY

DESIGN

We performed a population-based study of women aged 18 to 45 years with stage I gynecologic or stage I to III breast cancer reported to the California Cancer Registry for the years 2000 to 2012. Data were linked to the 2000 to 2012 California birth data to produce a database with cancer characteristics and obstetric outcomes. We included patients who had a delivery within the 10 months following cancer diagnosis. The primary outcome was severe maternal morbidity. Secondary outcomes included preterm birth and neonatal morbidity. Propensity scores were used to match similar controls to cases in a 2:1 ratio based on demographic attributes and medical comorbidities included in the Obstetric Comorbidity Index. Logistic regressions were used to evaluate outcomes.

RESULTS

The cohort consisted of 503 women with cancer in pregnancy (319 breast, 125 ovarian, 59 cervical) and 1006 matched controls. Cancer during pregnancy was associated with higher odds of severe maternal morbidity (6.8% vs <1.1%; odds ratio 8.03, 95% confidence interval 3.82-16.88), preterm birth between 32 and 36 weeks (32.6% vs 8.3%, odds ratio 5.38, 95% confidence interval 4.02-7.20), and neonatal morbidity (12.5% vs 6.1%; odds ratio 2.22, 95% confidence interval 1.53-3.21) compared to matched controls. In subanalysis of severe maternal morbidity indicators, hysterectomy and sepsis were significantly associated with cancer during pregnancy (4.8% vs <1.1%, P<.001; <2.2% vs 0.0%, P=.037, respectively).

CONCLUSION

Cancer during pregnancy is associated with increased risk of maternal and neonatal morbidity. These findings highlight the need for careful management and consideration of obstetric outcomes in these patients.

Для цитирования: Kanbergs Alexa, Clapp Mark, Wu Chi-Fang, Melamed Alexander, Agusti Nuria, Viveros-Carreño David, Zamorano Abigail S, Virili Florencia, Rauh-Hain Jose Alejandro, Nitecki Wilke Roni. Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity.. American journal of obstetrics and gynecology. 2024. DOI: 10.1016/j.ajog.2024.10.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.